Sanctuary Advisors LLC Has $377,000 Position in Innospec Inc. (NASDAQ:IOSP)

Sanctuary Advisors LLC raised its position in Innospec Inc. (NASDAQ:IOSP) by 63.6% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,152 shares of the specialty chemicals company’s stock after acquiring an additional 1,225 shares during the quarter. Sanctuary Advisors LLC’s holdings in Innospec were worth $377,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in IOSP. Allspring Global Investments Holdings LLC lifted its stake in shares of Innospec by 4.6% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 2,405,770 shares of the specialty chemicals company’s stock worth $272,069,000 after buying an additional 105,311 shares during the last quarter. Royce & Associates LP lifted its stake in shares of Innospec by 9.3% during the 3rd quarter. Royce & Associates LP now owns 835,333 shares of the specialty chemicals company’s stock worth $94,468,000 after buying an additional 70,902 shares during the last quarter. Edgestream Partners L.P. acquired a new stake in shares of Innospec during the 3rd quarter worth about $5,486,000. Cubist Systematic Strategies LLC lifted its stake in shares of Innospec by 117.3% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 81,311 shares of the specialty chemicals company’s stock worth $10,049,000 after buying an additional 43,898 shares during the last quarter. Finally, Victory Capital Management Inc. lifted its stake in shares of Innospec by 4.8% during the 3rd quarter. Victory Capital Management Inc. now owns 908,032 shares of the specialty chemicals company’s stock worth $102,689,000 after buying an additional 41,449 shares during the last quarter. Institutional investors and hedge funds own 96.64% of the company’s stock.

Innospec Stock Performance

NASDAQ IOSP opened at $110.66 on Friday. Innospec Inc. has a 52-week low of $103.97 and a 52-week high of $133.71. The stock has a market cap of $2.76 billion, a PE ratio of 19.31 and a beta of 1.09. The firm has a 50-day moving average of $115.16 and a 200-day moving average of $116.46.

Innospec (NASDAQ:IOSP) last released its quarterly earnings results on Tuesday, November 5th. The specialty chemicals company reported $1.35 EPS for the quarter, hitting analysts’ consensus estimates of $1.35. Innospec had a net margin of 7.68% and a return on equity of 13.33%. The business had revenue of $443.40 million for the quarter, compared to analyst estimates of $442.13 million. During the same period last year, the firm earned $1.59 earnings per share. Innospec’s revenue for the quarter was down 4.5% compared to the same quarter last year. As a group, analysts predict that Innospec Inc. will post 5.88 EPS for the current fiscal year.

Innospec Increases Dividend

The firm also recently declared a Semi-Annual dividend, which was paid on Tuesday, November 26th. Investors of record on Monday, November 18th were given a dividend of $0.79 per share. This represents a yield of 1.3%. This is a positive change from Innospec’s previous Semi-Annual dividend of $0.72. The ex-dividend date of this dividend was Monday, November 18th. Innospec’s dividend payout ratio (DPR) is currently 27.57%.

Insider Buying and Selling

In other Innospec news, Director Milton C. Blackmore sold 1,035 shares of the firm’s stock in a transaction dated Wednesday, November 13th. The shares were sold at an average price of $122.92, for a total value of $127,222.20. Following the transaction, the director now directly owns 9,028 shares of the company’s stock, valued at $1,109,721.76. This trade represents a 10.29 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.52% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Separately, StockNews.com cut shares of Innospec from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, December 18th.

Innospec Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.